To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

CSF α-synuclein and UCH-L… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.

Journal article
Authors Stefania Mondello
Radu Constantinescu
Henrik Zetterberg
Ulf Andreasson
Björn Holmberg
Andreas Jeromin
Published in Parkinsonism & related disorders
Volume 20
Issue 4
Pages 382–387
ISSN 1873-5126
Publication year 2014
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Pages 382–387
Language en
Keywords α-Synuclein; UCH-L1; Cerebrospinal fluid; Parkinson's disease; Atypical parkinsonian disorders
Subject categories Neurochemistry


There is an unmet need for biomarkers for Parkinson's disease (PD) and atypical parkinsonian disorders (APD). α-Synuclein, linked to the pathogenesis of PD, is a promising biomarker candidate in need of further investigation. The ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), a pivotal component of the ubiquitin proteasome system which seems to be disturbed in PD, may also be involved in the pathogenesis of this disorder.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?